Margate, FLNCT07401381Now EnrollingIRB Ready

Hormone Receptor Positive Early Breast Cancer Clinical Trial in Margate, FL

Access cutting-edge hormone receptor positive early breast cancer treatment through this phase 1 clinical trial at a research site in Margate. Study-provided care at no cost to qualified participants.

Sponsored by Rovi Pharmaceuticals Laboratories

Quick Self-Assessment

See if you qualify for this Margate location

Preparing your pre-screening questions…

Expert Care in Margate

Access hormone receptor positive early breast cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hormone receptor positive early breast cancer treatment provided free

Apply for This Margate Location

Check if you qualify for this hormone receptor positive early breast cancer clinical trial in Margate, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Margate

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Margate site if eligible
  4. 4Begin participation

About This Hormone Receptor Positive Early Breast Cancer Study in Margate

The study aims to compare the amount of the drug letrozole that gets into the bloodstream after multiple doses of the quarterly injection Letrozole SIE, versus multiple doses of the standard oral daily tablet of letrozole (Femara®), in women who have gone through menopause and have received treatment for hormone receptor-positive early breast cancer. Participants must have completed at least five years of hormone therapy with at least two of those years with letrozole before starting their participation in the study. Women who have completed four years of hormone therapy are also eligible if their doctor considers them at low risk of cancer returning.

Sponsor: Rovi Pharmaceuticals Laboratories

Who Can Participate

Inclusion Criteria

Women with weight of ≥50 kg and a Body Mass Index (BMI) ≥19 kg/m2 and ≤39 kg/m2
Postmenopausal women.
Women with confirmed diagnosis of HR+/HER2- or HR+/HER2+ early stage breast cancer who have completed at least 5 years of endocrine therapy, at least 2 years of which were with letrozole. Participants at a low risk of relapse, as assessed by the investigator, can also be eligible after completing 4 years of adjuvant endocrine therapy, at least 2 of which were with letrozole.
Women in good health.
Women who have undergone breast imaging per applicable guidelines (e.g., mammogram) within the last 12 months with no evidence of malignancy (documentation required), and if not done, must be willing to have 1 performed prior to baseline.

Exclusion Criteria

Presence of an uncontrolled, unstable, clinically significant medical condition.
Have used estrogen or progesterone systemic or topical therapy, oral contraceptives, androgens, LH-releasing hormone analogs, prolactin inhibitors, or antiandrogens within 3 months prior to screening.
Use of inducers or inhibitors of CYP3A4 and CYP2A6.
Diagnosed with osteoporosis.
Preexisting cardiovascular disease
Positive result for hepatitis B surface antigen, hepatitis B core antibody, hepatitis C antibody, or HIV antibodies.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Margate?

Yes, this clinical trial (NCT07401381) has an active research site in Margate, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hormone Receptor Positive Early Breast Cancer Treatment Options in Margate, FL

If you're searching for hormone receptor positive early breast cancer treatment options in Margate, FL, this clinical trial (NCT07401381) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Margate research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced hormone receptor positive early breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hormone receptor positive early breast cancer clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Margate, FL

See all breast cancer clinical trials recruiting in Margate — not just this study.

Browse Breast Cancer Trials in Margate →

Browse More Trials by Condition

Breast Cancer TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Margate?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Margate, FL